Navigation Links
RxAnte Closes Series A Financing
Date:9/12/2012

MCLEAN, Va., Sept. 12, 2012 /PRNewswire/ -- RxAnte, Inc., a health care improvement company providing a new and innovative approach for improving medication adherence, announced today that it has raised a Series A financing led by Aberdare Ventures with additional support from the West Health Investment Fund. The financing will be used to further develop RxAnte's proprietary technologies, commercialize its current offerings, and expand the company's impact on the quality of medication use.

"Adherence to prescribed medicine is a critical issue for a variety of health care organizations, and one of the biggest opportunities to improve health care," said Dr. Josh Benner, Founder and CEO of RxAnte. "RxAnte has pioneered a promising new approach to getting the right adherence interventions to the right patients at the right time. In collaboration with Aberdare and West Health, we're excited to expand our offerings and help more organizations achieve higher quality care at lower cost."

RxAnte uses its patent-pending analytics platform to predict medication adherence for individual patients, target interventions to those most likely to benefit, and monitor and manage programs over time. The RxAnte system reveals which patients respond best to interventions, helping organizations improve the cost-effectiveness of their adherence improvement efforts.

"We are elated to be teaming up with RxAnte," said Paul Klingenstein, Managing Partner at San Francisco-based Aberdare Ventures. "Drug adherence is a simple way to improve care for individuals and get more for our health care dollars. RxAnte has developed a set of superb data tools to accomplish these goals. It is exactly what our health care system needs, and the kind of thing we are trying to do at Aberdare."

RxAnte is currently working with major health plans, providers, care management organizations and pharmaceutical companies to help improve the effectiveness and efficiency of their adh
'/>"/>

SOURCE RxAnte, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. West Health Investment Fund invests in GlySens and RxAnte
2. Aethlon Medical Discloses MD Anderson Cancer Center Presentation
3. Intercept Pharmaceuticals Closes $30 Million Series C Financing
4. Solta Medical, Inc. Closes Public Offering of Common Stock
5. Chiasma Closes $38.5 Million Equity Financing
6. PTC Therapeutics Closes $30 Million Financing
7. BONESUPPORT Closes Second Tranche of Funding
8. Igenica Closes $33 Million in Series C Funding
9. C8 MediSensors Closes $19 million Preferred Stock Financing
10. Boston Scientific Closes Cameron Health Acquisition
11. Stereotaxis Closes $18.5 Million Private Placement Financings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... BRAINTREE, Mass. , June 19, 2013 /PRNewswire/ ... announced several important developments in the pursuit of ... (Logo: http://photos.prnewswire.com/prnh/20120206/NE47232LOGO ) , ... SANM ) for the future production of medical ... , Massachusetts. Sanmina is a leading global provider of ...
(Date:6/19/2013)... Dr. Davis Lee , CMIO for PIH Health ... 2013 AMDIS Award, a prestigious recognition saluting excellence and ... "On behalf of Allscripts, I,d like to congratulate Dr. ... efforts to improve patient care and population health," said ... Officer of Allscripts. "We are committed to our partnership ...
(Date:6/19/2013)... -- The American Association for Homecare (AAHomecare), along with a ... announced today the filing of a lawsuit in ... asking that the scheduled July 1 expansion of the Medicare ... stopped because of serious licensing irregularities. The lawsuit ... Secretary Kathleen Sebelius as the defendant. HHS oversees ...
Breaking Medicine Technology:Haemonetics Announces Next Steps in Manufacturing Transformation 2Haemonetics Announces Next Steps in Manufacturing Transformation 3Haemonetics Announces Next Steps in Manufacturing Transformation 4Allscripts Congratulates Dr. Davis Lee, Winner of the 2013 Association of Medical Directors of Information Systems (AMDIS) Award 2Allscripts Congratulates Dr. Davis Lee, Winner of the 2013 Association of Medical Directors of Information Systems (AMDIS) Award 3Allscripts Congratulates Dr. Davis Lee, Winner of the 2013 Association of Medical Directors of Information Systems (AMDIS) Award 4Allscripts Congratulates Dr. Davis Lee, Winner of the 2013 Association of Medical Directors of Information Systems (AMDIS) Award 5AAHomecare and Maryland DME Provider Take Medicare Agency to Court Over Competitive Bidding Program 2AAHomecare and Maryland DME Provider Take Medicare Agency to Court Over Competitive Bidding Program 3AAHomecare and Maryland DME Provider Take Medicare Agency to Court Over Competitive Bidding Program 4AAHomecare and Maryland DME Provider Take Medicare Agency to Court Over Competitive Bidding Program 5
... Agent Ever to Demonstrate Significant Survival Benefit ... /PRNewswire-FirstCall/ -- Bayer,HealthCare Pharmaceuticals Inc. and Onyx ... significantly,extended overall survival in patients with hepatocellular ... taking placebo by 44%,(HR=0.69; p-value=0.0006). Results were ...
... WIRE)--Jun 4, 2007 - Researchers at,Molecular Insight ... on MIP-1072, a radiolabeled, small molecule,molecular imaging ... prostate cancer at the 54th annual meeting ... Washington, D.C. MIP-1072 is,one of two development ...
Cached Medicine Technology:Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 2Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 3Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 4Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 5Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 6Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 7Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data,on Molecular Imaging Pharmaceutical for Prostate Cancer 2Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data,on Molecular Imaging Pharmaceutical for Prostate Cancer 3Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data,on Molecular Imaging Pharmaceutical for Prostate Cancer 4
(Date:6/19/2013)... Today, Zane Benefits, Inc. published new ... Zane Benefits, which provides comprehensive and flexible alternatives to ... defined contribution and health reimbursement arrangement ... part of the Affordable Care Act (ACA), health insurance ... through new state health insurance exchanges. , Most importantly, ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 As ... cancer continue to mount in courts throughout the U.S., ... Drug Administration (FDA) recently held a meeting to discuss ... as incretin mimetics. According to a June 12th ... from the makers of Januvia and similar drugs, following ...
(Date:6/19/2013)... and trauma surgery have had a significant impact ... after major injuries, including burns. Patients who ... are at greatest risk from infections particularly ... or from inflammation-induced multiorgan failure. Now, ... investigators that measures the movement of key immune ...
(Date:6/19/2013)... June 19 online edition of the journal Nature ... University of California, San Diego School of Medicine visually ... cardiac regeneration occurs in zebrafish after cardiac ventricular injury. ... in the heart are more plastic, or capable of ... More importantly, the research reveals a novel potential source ...
(Date:6/19/2013)... Children had half as many emergency department visits ... on five or more days a week, according to ... Children,s Hospital and Johns Hopkins University. , The new ... Journal of Pediatrics and will be presented at ... an important step in understanding where primary care practices ...
Breaking Medicine News(10 mins):Health News:Zane Benefits Publishes New Information on the Wisconsin Health Insurance Exchange 2Health News:Zane Benefits Publishes New Information on the Wisconsin Health Insurance Exchange 3Health News:Januvia Lawsuit News: Bernstein Liebhard LLP Comments on Recent FDA Meeting to Discuss Safety of Januvia and Other Incretin Mimetics 2Health News:Januvia Lawsuit News: Bernstein Liebhard LLP Comments on Recent FDA Meeting to Discuss Safety of Januvia and Other Incretin Mimetics 3Health News:Restoring appropriate movement to immune cells may save seriously burned patients 2Health News:Restoring appropriate movement to immune cells may save seriously burned patients 3Health News:Fate of the heart: Researchers track cellular events leading to cardiac regeneration 2Health News:Extended primary care office hours might help keep kids out of the emergency department 2
... President Barak Obama speaks to the American Medical Association (AMA) ... nation, including physicians from coast to coast, is listening. ... AMA will not support a public health insurance, option. Since ... taking an anti-public insurance stance, the AMA is fostering the ...
... PF Advocate, and Top PF Researcher and Clinician , , ... today announced its co-founder and other Pulmonary Fibrosis (PF) experts will ... Radio" on Tuesday, June 16th from 6-7 a.m. EDT. For ... a free pass available on the Internet. , ...
... but there are potential risks , MONDAY, June 15 (HealthDay ... the purported cholesterol-lowering effects of the centuries-old natural product called ... a yeast, Monascus purpureus , is grown on rice. ... a thousand years as food and medicine. In the United ...
... , Experts from Northwestern Memorial,s Bluhm Cardiovascular Institute open their ... and surgery , , CHICAGO, June 15 ... looking forward to their senior year of high school. Though ... part of the Cardiology Summer Academy (CSA) at Northwestern Memorial ...
... not help others with mild memory loss, study finds, ... increase the chance of developing Alzheimer,s disease among those ... But the drug donepezil (Aricept), commonly prescribed for people ... the disease, the study also found. , The findings ...
... , , WAYNE, Pa., June 15 ... best spine products, engineering teams and inventors for 2009. ... exclusively on rewarding excellence and innovation. , , ... for Cervical Care, Lumbar Care, Motion Preservation of the ...
Cached Medicine News:Health News:Indiana U. expert says nation's physicians support national health insurance 2Health News:CPF, Pulmonary Fibrosis Experts Guests on Sirius and XM Satellite Radio Show June 16th 2Health News:A Substitute for Those Who Can't Take Statins? 2Health News:A Substitute for Those Who Can't Take Statins? 3Health News:Teens as Cardiologists in Training: Program Swaps Backpacks for Stethoscopes 2Health News:Teens as Cardiologists in Training: Program Swaps Backpacks for Stethoscopes 3Health News:Teens as Cardiologists in Training: Program Swaps Backpacks for Stethoscopes 4Health News:Drug May Stem Slide Into Alzheimer's for Some 2Health News:First Spine Technology Awards to Recognize Excellence and Innovation 2
... Independent controls for Digital Thermostat and ... clad steel. , Interiorwhite anodized aluminum ... , Oversized refrigeration (134A). , Temperature ... seal self-closing doors. , Foamed-in-place polyurethane ...
Inquire...
... The K Series CryoStorage System ... of liquid nitrogen stroage from -100C ... of solid-state automatic controls, easy accessibility ... at crogenic termperatures. On the larger ...
... refrigerators from Taylor-Wharton are uniquely designed to ... box-type storage racks and the lower operating ... The RackSystems are available in four convenient ... 750 x 2ml vials to 4800 x ...
Medicine Products: